The U.S. Food and Drug Administration (FDA) plans to consult a panel of experts before clearing additional COVID-19 vaccine booster shots. The current plan is “to gather our independent panel of outside experts next month to have a transparent discussion about considerations for 2022 booster shots, including whether and when those boosters may be needed and for which populations, based on the available data and latest science on circulating or emerging virus variant,” an FDA spokeswoman told The Epoch Times via email. The meeting date has not yet been made known. Pfizer is seeking emergency use authorization (EUA) for a second booster dose for all Americans 65 and older. Moderna is seeking emergency authorization for a second booster for all adults 18 and older. Upon receipt of such requests, the FDA typically convenes the Vaccines and Related Biological Products Advisory Committee. Panel members are asked whether the regulatory agency should …